Geometry Dash APK Hill Climb Racing APK
79.9 F
New York
Monday, August 15, 2022

Sorrento Therapeutics (NASDAQ:SRNE) Continues to gain Momentum On Positive News

Must read

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...

Net Savings Link Inc (OTCMKTS:NSAV) Goes Parabolic Ahead of Important Event

As far as cryptocurrency and blockchain companies are concerned, there are many options nowadays for investors to explore.

Many biopharmaceutical companies have seen their stocks surge in recent months for a variety of reasons and one such stock is Sorrento Therapeutics Inc (NASDAQ:SRNE). SRNE surged again on Monday by as much as 20% and it could be worthwhile for investors to take a closer look at the recent developments.

Clinical Trial Of  Abivertinib

On Monday, the company announced that the concerned regulators have given the green light for the clinical trial of its product Abivertinib. The product in question is a tyrosine kinase inhibitor. It goes without saying that it is a massive development for the company and the reaction in the market was understandable.

It was back in May this year that Sorrento struck an agreement with ACEA Therapeutics for licensing Abivertinib. Yesterday, the United States Food and Drug Administration gave Sorrento the much-needed clearance to start a Phase 2 trial of the product on COVID 19 patients. The patients in question are going to have moderate to extreme lung-related symptoms.

The Phase 2 trial will evaluate the effectiveness of the medicine on those suffering from moderate to extreme COVID 19 related lung problems. Investors need to note that Abivertinib is expected to be found to be safe and that could be another positive to be kept in mind.

The product is known for shutting off two different signals to the cells that can cause inflammation and the unchecked variety of these inflammations are called cytokine storms. Cytokine storms are particularly dangerous for COVID 19 patients considering the fact that their lungs are filled with both deal cells and fluids.

The senior vice president of regulatory affairs at Sorrento, Mark Brunswick, stated that he hopes that Abivertinib will help patients in getting back to their ‘normal lives’. Considering the current situation caused by the coronavirus pandemic, the new product for Sorrento is another ray of hope for people and investors could do well to keep an eye on the developments. Sign up below for critical alerts on SRNE and other breakout stocks.

Latest article

Alibaba Group Holding Limited (OTCMKTS:BABAF) Big Volume with Possible 60% Upside

Alibaba Group Holding Limited (OTCMKTS:  BABAF) is an over the counter stock traded on the OTC Pink markets in the Consumer Discretionary...

Trans Global Group Inc (OTCMKTS:TGGI) Stock In Focus After Operational Updates

The Trans Global Group Inc (OTCMKTS:TGGI) stock may not have been in the news today yet but it...

Why Hycroft Mining (NASDAQ:HYMC) Stock Shot Up 700%

If you are on the hunt for stocks that may have made major gains over the course of the past week, then...

Secure Paymentz releases banking software demo on Github

This is a paid announcement from one of our advertising partners. How to Leverage Your Trading Position by Secure...

Advanced Asset Management Announces New Website Launch

This is a paid announcement from one of our advertising partners. Financial Planner in Grandville, Michigan
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service